Research output per year
Research output per year
Fingerprint
Dive into the research topics where Anna Tocheva is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Erratum: Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer (Cell Reports Medicine (2024) 5(12), (S2666379124006232), (10.1016/j.xcrm.2024.101852))
Chakraborty, S., Sen, U., Ventura, K., Jethalia, V., Coleman, C., Sridhar, S., Banerjee, A., Ozakinci, H., Mahendravarman, Y., Snioch, K., de Stanchina, E., Shields, M. D., Tomalin, L. E., Demircioglu, D., Boyle, T. A., Tocheva, A., Hasson, D. & Sen, T., 18 Feb 2025, In: Cell Reports Medicine. 6, 2, 101944.Research output: Contribution to journal › Comment/debate
Open Access -
Protocol to co-culture SCLC cells with human CD8+ T cells to measure tumor cell killing and T cell activation
Chakraborty, S., Sridhar, S., Ventura, K., Sritharan, R., Tocheva, A. & Sen, T., 20 Jun 2025, In: STAR Protocols. 6, 2, 103767.Research output: Contribution to journal › Article › peer-review
-
Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer
Chakraborty, S., Sen, U., Ventura, K., Jethalia, V., Coleman, C., Sridhar, S., Banerjee, A., Ozakinci, H., Mahendravarman, Y., Snioch, K., de Stanchina, E., Shields, M. D., Tomalin, L. E., Demircioglu, D., Boyle, T. A., Tocheva, A., Hasson, D. & Sen, T., 17 Dec 2024, In: Cell Reports Medicine. 5, 12, 101852.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Single-Cell View of Tumor Microenvironment Gradients in Pleural Mesothelioma
Giotti, B., Dolasia, K., Zhao, W., Cai, P., Sweeney, R., Merritt, E., Kiner, E., Kim, G. S., Bhagwat, A., Nguyen, T., Hegde, S., Fitzgerald, B. G., Shroff, S., Dawson, T., Garcia-Barros, M., Abdul-Ghafar, J., Chen, R., Gnjatic, S., Soto, A. & Brody, R. & 11 others, , 1 Nov 2024, In: Cancer Discovery. 14, 11, p. 2262-2278 17 p.Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations -
Transmembrane domain–driven PD-1 dimers mediate T cell inhibition
Philips, E. A., Liu, J., Kvalvaag, A., Mørch, A. M., Tocheva, A. S., Ng, C., Liang, H., Ahearn, I. M., Pan, R., Luo, C. C., Leithner, A., Qin, Z., Zhou, Y., Garcia-España, A., Mor, A., Littman, D. R., Dustin, M. L., Wang, J. & Kong, X. P., Mar 2024, In: Science immunology. 9, 93, ,eade6256.Research output: Contribution to journal › Article › peer-review
Open Access18 Scopus citations
Press/Media
-
Studies from Icahn School of Medicine at Mount Sinai Describe New Findings in Lung Cancer (Lurbinectedin Sensitizes Pd-l1 Blockade Therapy By Activating Sting-ifn Signaling In Small-cell Lung Cancer)
Tocheva, A., Sen, T., Sen, U. & Tomalin, L.
12/03/25
1 item of Media coverage
Press/Media
-
New Autoimmunity Findings Reported from New York University (NYU) (Transmembrane Domain-driven Pd-1 Dimers Mediate T Cell Inhibition)
11/04/24
1 item of Media coverage
Press/Media
-
“Double Life” of Key Immune Protein Reveals New Strategies for Treating Cancer
1/04/24
1 item of Media coverage
Press/Media
-
-
“Double life” of key immune protein reveals new strategies for treating cancer and autoimmune diseases
11/03/24
1 item of Media coverage
Press/Media